两种自动化免疫分析法用于抗核抗体筛查的临床性能评估
该研究评估了EliA CTD Screen与QUANTA Flash CTD Screen Plus两种全自动免疫分析法在抗核抗体筛查中的临床性能,并与间接免疫荧光法(IIFA)进行比较。共检测406份血清样本,结果显示两种自动化方法之间一致性高,与IIFA一致性较弱至中等,调整临界值后可提高诊断ANA相关风湿病的敏感性。
要点
- 在风湿科样本中,EliA与QUANTA Flash一致性为91.5%,一致性强度强。
- 自动化方法阳性而IIFA阴性的样本中,检出的抗ENA抗体均为抗Ro60抗体。
- 调整临界值后EliA敏感性82.9%,QUANTA Flash敏感性87.8%。
核心结论
- 两种自动化免疫分析法与IIFA相比性能可靠,可在临床免疫实验室中与IIFA联合使用。
研究设计与样本
- 共纳入406份血清样本,其中206份来自常规体检患者,200份来自风湿科门诊患者,同时用EliA、QUANTA Flash和IIFA检测。
主要发现
- 在风湿科样本中,EliA与QUANTA Flash一致性为91.5%且强度强,EliA与IIFA一致性为79.0%且强度弱,QUANTA Flash与IIFA一致性为80.5%且强度中等。
- 在自动化方法阳性而IIFA阴性的样本(N=15)中,检出的抗ENA抗体(6/15)均为抗Ro60抗体。
- 自动化方法与IIFA对诊断ANA相关风湿病均显示高准确性,调整临界值后EliA(比值0.56)敏感性为82.9%,QUANTA Flash(9.7化学发光单位)敏感性为87.8%。
关键数值与推荐
- EliA调整临界值为0.56比值时敏感性82.9%。
- QUANTA Flash调整临界值为9.7化学发光单位时敏感性87.8%。
临床怎么用
- 临床免疫实验室可将自动化免疫分析法与IIFA联合用于抗核抗体筛查。
- 各实验室可根据自身工作流程调整临床临界值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recently, two fully automated immunoassays for antinuclear antibody (ANA) screening were introduced: EliA CTD Screen (Thermo Fisher Scientific, Freiburg, Germany) and QUANTA Flash CTD Screen Plus (Inova Diagnostics, San Diego, USA). We evaluated their clinical performance in comparison with the indirect immunofluorescence assay (IIFA) and analyzed samples with discrepant results. METHODS: In total, 406 serum samples (206 from patients undergoing routine checkups and 200 from rheumatology clinic patients) were assayed using EliA, QUANTA Flash, and IIFA. We evaluated assay concordance and agreement and confirmed the presence of anti-extractable nuclear antigen (ENA) antibodies in samples with discrepant automated immunoassay and IIFA results. Additionally, we compared the clinical performance of each assay in diagnosing ANA-associated rheumatic disease (AARD) and adjusted the cut-off values. RESULTS: In rheumatology clinic samples, the concordance and agreement were 91.5% and strong between EliA and QUANTA Flash, 79.0% and weak between EliA and IIFA, and 80.5% and moderate between QUANTA Flash and IIFA, respectively. In automated immunoassay-positive, IIFA-negative samples (N=15), all anti-ENA antibodies detected (6/15) were anti-Sjögren's syndrome antigen A/Ro (Ro60) antibodies. The automated immunoassays and IIFA showed high accuracy for diagnosing AARD, and adjusted cut-off values improved their sensitivities (EliA with 0.56 ratio, 82.9% sensitivity; QUANTA Flash with 9.7 chemiluminescent units, 87.8% sensitivity). CONCLUSIONS: The two automated immunoassays showed reliable performance compared with IIFA and can be efficiently used with the IIFA in clinical immunology laboratories. Clinical cut-off values can be adjusted according to the workflow in each laboratory.
引用
- Yoon S, Moon HW, Kim H, et al. Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening. Ann Lab Med. 2022. PMID: 34374350. doi:10.3343/alm.2022.42.1.63
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。